ARCHIVES

President’s Cancer Panel annual report finds barriers in translational research stall progress.

This article is from The Cancer Letter archive.

Vol. 31 No. 27 | July 8, 2005

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Bush Names 8 to NCAB.

June 13, 2008

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

In Breif: Folkman selected For Karnofsky Lecture; Sporn to give ACS Lecture At ASCO

February 2, 1996